These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 15606790)

  • 1. Intratumoral immunotherapy: using the tumour against itself.
    Crittenden MR; Thanarajasingam U; Vile RG; Gough MJ
    Immunology; 2005 Jan; 114(1):11-22. PubMed ID: 15606790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunology in medical practice. XXV. Use of dendritic cells in the immunotherapy of cancer].
    Punt CJ; de Vries IJ; Mulders PF; Adema GJ; Figdor CG
    Ned Tijdschr Geneeskd; 1999 Nov; 143(48):2408-14. PubMed ID: 10608974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kickstarting Immunity in Cold Tumours: Localised Tumour Therapy Combinations With Immune Checkpoint Blockade.
    Appleton E; Hassan J; Chan Wah Hak C; Sivamanoharan N; Wilkins A; Samson A; Ono M; Harrington KJ; Melcher A; Wennerberg E
    Front Immunol; 2021; 12():754436. PubMed ID: 34733287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo manipulation of dendritic cell migration and activation to elicit antitumour immunity.
    Vicari AP; Vanbervliet B; Massacrier C; Chiodoni C; Vaure C; Aït-Yahia S; Dercamp C; Matsos F; Reynard O; Taverne C; Merle P; Colombo MP; O'Garra A; Trinchieri G; Caux C
    Novartis Found Symp; 2004; 256():241-54; discussion 254-69. PubMed ID: 15027495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review: the application of dendritic cell-derived exosomes in tumour immunotherapy.
    Quah B; O'Neill HC
    Cancer Biother Radiopharm; 2000 Apr; 15(2):185-94. PubMed ID: 10803324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy II: Antigens, receptors and costimulation.
    Searle PF; Young LS
    Cancer Metastasis Rev; 1996 Sep; 15(3):329-49. PubMed ID: 9034595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive networks in the tumour environment and their therapeutic relevance.
    Zou W
    Nat Rev Cancer; 2005 Apr; 5(4):263-74. PubMed ID: 15776005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer.
    Jäger D; Jäger E; Knuth A
    J Clin Pathol; 2001 Sep; 54(9):669-74. PubMed ID: 11533070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immuno-oncology: understanding the function and dysfunction of the immune system in cancer.
    Finn OJ
    Ann Oncol; 2012 Sep; 23 Suppl 8(Suppl 8):viii6-9. PubMed ID: 22918931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity.
    Carmi Y; Spitzer MH; Linde IL; Burt BM; Prestwood TR; Perlman N; Davidson MG; Kenkel JA; Segal E; Pusapati GV; Bhattacharya N; Engleman EG
    Nature; 2015 May; 521(7550):99-104. PubMed ID: 25924063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy exploiting the versatility of dendritic cells.
    Kadowaki N
    Ther Apher Dial; 2003 Jun; 7(3):312-7. PubMed ID: 12924606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting dendritic cells with antigen-containing liposomes: antitumour immunity.
    Altin JG; van Broekhoven CL; Parish CR
    Expert Opin Biol Ther; 2004 Nov; 4(11):1735-47. PubMed ID: 15500402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity.
    Hong S; Li H; Qian J; Yang J; Lu Y; Yi Q
    Clin Exp Immunol; 2012 Nov; 170(2):167-77. PubMed ID: 23039887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Local Radiation Therapy in Cancer Immunotherapy.
    Demaria S; Golden EB; Formenti SC
    JAMA Oncol; 2015 Dec; 1(9):1325-32. PubMed ID: 26270858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Antigen-Specific B Cells to Combine Antibody and T Cell-Based Cancer Immunotherapy.
    Wennhold K; Thelen M; Schlößer HA; Haustein N; Reuter S; Garcia-Marquez M; Lechner A; Kobold S; Rataj F; Utermöhlen O; Chakupurakal G; Theurich S; Hallek M; Abken H; Shimabukuro-Vornhagen A; von Bergwelt-Baildon M
    Cancer Immunol Res; 2017 Sep; 5(9):730-743. PubMed ID: 28778961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic immunotherapy for cancer.
    Ribas A; Butterfield LH; Economou JS
    Oncologist; 2000; 5(2):87-98. PubMed ID: 10794799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell-mediated immunotherapy of metastases: state of the art in 2005.
    Schirrmacher V
    Expert Opin Biol Ther; 2005 Aug; 5(8):1051-68. PubMed ID: 16050783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell fusion vaccines for cancer immunotherapy.
    Rosenblatt J; Kufe D; Avigan D
    Expert Opin Biol Ther; 2005 May; 5(5):703-15. PubMed ID: 15934845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy with dendritic cells as a cancer treatment: perspectives and therapeutic potential.
    Aleixo AA; Michelin MA; Murta EF
    Recent Pat Endocr Metab Immune Drug Discov; 2013 Sep; 7(3):226-32. PubMed ID: 23675964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How?
    Cancel JC; Crozat K; Dalod M; Mattiuz R
    Front Immunol; 2019; 10():9. PubMed ID: 30809220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.